{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T03:51:40Z","timestamp":1788580300887,"version":"build-2803163510"},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"HELEBOR"},{"name":"APICIL"},{"name":"Lions Club Paris Gait\u00e9"},{"name":"Assistance Publique \u2013H\u00f4pitaux de Paris"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,27]]},"abstract":"<jats:p>This prospective pilot interventional study aimed at studying the efficacy of cannabidiol on pruritus and pain on paediatric patients with recessive dystrophic epidermolysis bullosa. A decrease in average chronic pruritus and pain, pruritus and pain during dressing changes in addition to a significant improvement of quality-of-life scores and sleep were observed. No severe side effects were reported.<\/jats:p>","DOI":"10.1093\/bjd\/ljaf400","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T12:12:46Z","timestamp":1760703166000},"page":"375-378","source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic efficacy of cannabidiol on pruritus and pain in children with recessive dystrophic epidermolysis bullosa: a pilot study"],"prefix":"10.1093","volume":"194","author":[{"given":"Lara","family":"Mayrand","sequence":"first","affiliation":[{"name":"Department of Pain and Palliative Care Unit, Necker-Enfants Malades Hospital, AP-HP, Universite\u0301 Paris Cit\u00e9 , Paris ,","place":["France"]},{"name":"Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, Imagine Institute, Inserm, Universite\u0301 Paris Cit\u00e9 , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5362-5694","authenticated-orcid":false,"given":"Julie","family":"Bonigen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, National Reference Centre for Genodermatosis (MAGEC), Necker-Enfants Malades Hospital, Assistance Publique, H\u00f4pitaux de Paris (AP-HP), Universite\u0301 Paris Cit\u00e9 , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Marquant","sequence":"additional","affiliation":[{"name":"Unit\u00e9 de Recherche Clinique-Centre Investigation Clinique, H\u00f4pital Necker-Enfants Malades, Assistance Publique-H\u00f4pitaux de Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly","family":"Schinkel","sequence":"additional","affiliation":[{"name":"Department of Pain and Palliative Care Unit, Necker-Enfants Malades Hospital, AP-HP, Universite\u0301 Paris Cit\u00e9 , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalia","family":"Bellon","sequence":"additional","affiliation":[{"name":"Department of Dermatology, National Reference Centre for Genodermatosis (MAGEC), Necker-Enfants Malades Hospital, Assistance Publique, H\u00f4pitaux de Paris (AP-HP), Universite\u0301 Paris Cit\u00e9 , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Bataille","sequence":"additional","affiliation":[{"name":"Department of Dermatology, National Reference Centre for Genodermatosis (MAGEC), Necker-Enfants Malades Hospital, Assistance Publique, H\u00f4pitaux de Paris (AP-HP), Universite\u0301 Paris Cit\u00e9 , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Im\u00e8ne","family":"Fettouche","sequence":"additional","affiliation":[{"name":"Department of Dermatology, National Reference Centre for Genodermatosis (MAGEC), Necker-Enfants Malades Hospital, Assistance Publique, H\u00f4pitaux de Paris (AP-HP), Universite\u0301 Paris Cit\u00e9 , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Chaumon","sequence":"additional","affiliation":[{"name":"Department of Pain and Palliative Care Unit, Necker-Enfants Malades Hospital, AP-HP, Universite\u0301 Paris Cit\u00e9 , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Elie","sequence":"additional","affiliation":[{"name":"Unit\u00e9 de Recherche Clinique-Centre Investigation Clinique, H\u00f4pital Necker-Enfants Malades, Assistance Publique-H\u00f4pitaux de Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bodemer","sequence":"additional","affiliation":[{"name":"Department of Dermatology, National Reference Centre for Genodermatosis (MAGEC), Necker-Enfants Malades Hospital, Assistance Publique, H\u00f4pitaux de Paris (AP-HP), Universite\u0301 Paris Cit\u00e9 , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4259-6861","authenticated-orcid":false,"given":"Celine","family":"Greco","sequence":"additional","affiliation":[{"name":"Department of Pain and Palliative Care Unit, Necker-Enfants Malades Hospital, AP-HP, Universite\u0301 Paris Cit\u00e9 , Paris ,","place":["France"]},{"name":"Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, Imagine Institute, Inserm, Universite\u0301 Paris Cit\u00e9 , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"2026012706474995000_ljaf400-B1","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2147\/CCID.S232547","article-title":"From clinical phenotype to genotypic modelling: incidence and prevalence of recessive dystrophic epidermolysis bullosa (RDEB)","volume":"12","author":"Eichstadt","year":"2019","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2026012706474995000_ljaf400-B2","doi-asserted-by":"crossref","first-page":"551","DOI":"10.25259\/IJDVL_71_2021","article-title":"Purified oral cannabidiol for pain management in severe recessive dystrophic epidermolysis bullosa","volume":"88","author":"Welponer","year":"2022","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"2026012706474995000_ljaf400-B3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1186\/s13023-021-02010-0","article-title":"Cannabinoid use and effects in patients with epidermolysis bullosa: an international cross-sectional survey study","volume":"16","author":"Schr\u00e4der","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"2026012706474995000_ljaf400-B4","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1111\/pde.13545","article-title":"Self-initiated use of topical cannabidiol oil for epidermolysis bullosa","volume":"35","author":"Chelliah","year":"2018","journal-title":"Pediatr Dermatol"},{"key":"2026012706474995000_ljaf400-B5","doi-asserted-by":"crossref","first-page":"e00682","DOI":"10.1002\/prp2.682","article-title":"Diversity of molecular targets and signaling pathways for CBD","volume":"8","author":"de Almeida","year":"2020","journal-title":"Pharmacol Res Perspect"},{"key":"2026012706474995000_ljaf400-B6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.yebeh.2019.03.042","article-title":"Higher cannabidiol plasma levels are associated with better seizure response following treatment with a pharmaceutical grade cannabidiol","volume":"95","author":"Szaflarski","year":"2019","journal-title":"Epilepsy Behav"},{"key":"2026012706474995000_ljaf400-B7","doi-asserted-by":"crossref","first-page":"E295","DOI":"10.1002\/ajh.27049","article-title":"Dramatic efficacy of cannabidiol on refractory chronic pain in an adolescent with sickle cell disease","volume":"98","author":"Mayrand","year":"2023","journal-title":"Am J Hematol"},{"key":"2026012706474995000_ljaf400-B8","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3390\/biomedicines11020520","article-title":"The effectiveness and safety of pharmaceutical-grade cannabidiol in the treatment of mastocytosis-associated pain: a pilot study","volume":"11","author":"Rossignol","year":"2023","journal-title":"Biomedicines"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljaf400\/64755304\/ljaf400.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/194\/2\/375\/64755304\/ljaf400.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/194\/2\/375\/64755304\/ljaf400.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T11:47:53Z","timestamp":1769514473000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/194\/2\/375\/8292843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":8,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,10,17]]},"published-print":{"date-parts":[[2026,1,27]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljaf400","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,10,17]]}}}